![]() ![]() ![]() Roche manufactured the treatment at the Vacaville plant, which it sells outside the U.S. The plant makes drugs for cancer including Avastin and Herceptin, as well as Actemra for rheumatoid arthritis.ĭuring the pandemic, Roche collaborated with Regeneron Pharmaceuticals to increase supply of that drugmaker's COVID-19 antibody treatment. Roche acquired the plant more than a decade ago with its purchase of U.S. If the company is unable to find a buyer, it will ramp down production and close the plant in 2028 to 2029, the emails said. The company said it is seeking a buyer that will continue to use the plant as an operating facility. It is also contending with dipping revenue for its COVID-19 therapies and tests. ![]() The Swiss group is under pressure to develop new treatments to offset the loss of billions in sales due to cheap biotech copies of its established cancer medicines Herceptin, Avastin and Rituxan, some of which are made in Vacaville. Roche is under new leadership this year after CEO Thomas Schinecker took the helm and Teresa Graham became head of the pharmaceuticals division in March. We are committed to not only advancing diagnostic solutions that can support healthcare professionals in making critical decisions for their patients’ health, but also improving the way these essential tools are integrated into health systems around the world, at a lower cost, while still achieving the best possible outcomes. It also plans to focus on drugs targeting smaller patient populations moving forward and to draw on a range of biotechnology methods beyond monoclonal antibodies, it said, adding there would be no impact to operations or employees at this time. Roche Diagnostics is a division of Roche. ![]()
0 Comments
Leave a Reply. |